The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients in the US have received it yet.

This is the first case of H5N1 in the US this year that has sent a patient to the hospital.

A 53-year-old woman was the third to undergo the transplant procedure. Researchers are hoping to monitor the long-term effects.

Robert F. Kennedy Jr., Donald Trump’s pick to lead the US Department of Health and Human Services, has been vocally anti-pharma. Pharma, Congress, and the courts, though, all get a say.

Startup Phantom Neuro is building an implant that sits under the skin and which promises to give amputees more accurate control of electronic prosthetics.

Elon Musk’s brain implant company is launching a new study to test whether its wireless device can control a robotic arm.

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions online, despite a lack of evidence that they work.